Genting Pharmaceutical (Suzhou)

Everest Medicines is a commercial-stage biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products in Greater China and other emerging Asia Pacific markets. Headquartered in Shanghai with a major manufacturing and R&D base in Suzhou, the company targets high-growth therapeutic areas including renal diseases, infectious diseases, and autoimmune disorders. Everest employs a dual strategy of in-licensing late-stage global assets and developing an internal discovery pipeline, notably through its mRNA technology platform. Key commercial products include Nefecon for IgA nephropathy and Xerava for complicated intra-abdominal infections. The company is listed on the Hong Kong Stock Exchange and maintains strategic partnerships with global firms like Pfizer, Calliditas, and Kezar Life Sciences.